Committee & streams

The programme of the IDF World Diabetes Congress 2022 is organised across eight streams.

Basic and Translational 
Science (BTS)
Lead
Paula Macedo
Portugal
Members
Young-Bum Kim
USA
Norbert Stefan
Germany
Sung Hee Choi
South Korea
Clinical, Therapeutic
and Technology
Research (CTT)
Lead
Shashank Joshi
India
Members
David Klonoff
USA
Chantal Mathieu
Belgium
Pablo Aschner Monotoya
Columbia
Diabetes Complications
and Comorbidities (DCC)
Lead
Andrea Luk
China
Members
Kamlesh Khunti
United Kingdom
David Preiss
United Kingdom
George King
USA
Health Services and
Policy (HSP)
Lead
Niti Pall
United Kingdom
Members
Partha Kar
United Kingdom
Cajsa Lindberg
Sweden
Reem Fahd Al Bunyan
Kingdom of Saudi Arabia
Diabetes in Women (DIW)
Lead
Maria Inês Schmidt
Brazil
Members
Usha Siriam
India
Caroline Kramer
Canada
David Simmons
Australia
Education and
Integrated Care (EIC)
Lead
Zilin Sun
China
Members
Rajata Rajatanavin
Thailand
Tatjana Milenkovic
Macedonia
Edwin B Fisher
USA
Epidemiology and
Public Health (EPH)
Lead
Ayesha Motala
South Africa
Members
Elizabeth Selvin
USA
Edward Gregg
United Kingdom
Abdul Basit
Pakistan
Living with Diabetes (LWD)
Lead
Sana Ajmal
Pakistan
Members
Georgina Peters
Australia
Sebastian Hauck
Germany
Mila Clarke Buckley
USA

Programme Chair: Jonathan Shaw, Australia

Jonathan Shaw MD, FRCP (UK), FRACP, FAAHMS is Deputy Director at Melbourne’s Baker Heart and Diabetes Institute. He is also an Endocrinologist, Chair of the Diabetes Advisory Group to the Australian Institute of Health and Welfare (AIHW), Council Member of the Australian Diabetes Society, and Past-President of the International Diabetes Epidemiology Group (IDEG). His awards include the IDEG Peter Bennett Award (2011), the Australian Diabetes Society (ADS) Jeff Flack Diabetes Data Award (2015), and the ADS Kellion Diabetes Award (2018). He has authored more than 400 peer-reviewed scientific papers and 35 book chapters, and was included in the Thomson Reuters The World’s Most Influential Scientific Minds (2014), and the Clarivate Analytics list of the world’s most Highly Cited Researchers (2017 and 2018). His areas of interest include epidemiology and clinical trials in diabetes.

Vice Chair: João Valente Nabais, Portugal

João Valente Nabais PhD is Assistant Profesor with Habilitation at the University of Evora (Portugal). Diagnosed with type 1 diabetes in 1981, João has been actively involved in diabetes at the national and international level. He has been involved in diabetes camps and the development of educational courses for people with diabetes and parents of children with diabetes, and oversaw the launch of the IDF Europe Youth Leadership Camp. João is a member of the Comprehensive Health Research Center and a consultant to the Portuguese Diabetes Association (APDP). He is a Past President of the IDF European Region (2012-15) and currently a Vice-President of IDF. He has published 60 papers in international journals, participated in 15 R&D projects as Researcher and is the co-author of 3 patents.

STREAM LEADS

Basic and Translational Science: Paula Macedo

Paula Macedo is currently Professor at the NOVA Medical School, NOVA University in Lisbon, and at the Department of Medical Sciences Universidade Aveiro, Portugal. Professor Macedo graduated in Pharmacy from the Faculty of Pharmacy at the University of Lisbon and obtained her PhD from the Department of Pharmacology and Therapeutics at the University of Manitoba, Canada. She is the principal investigator of the MEDIR group based at CEDOC NOVA Medical School. Professor Macedo has been awarded several grants as a principal investigator on her preferred research subjects in both basic and clinical research. She has been working in research areas related to hepatic vasculature and hepatic control of insulin sensitivity. Her significant contributions include the description and explanation of meal-induced insulin action sensitization in prediabetes and diabetes-related pathologies.

Diabetes Complications and Comorbidities : Andrea Luk

Andrea Luk is currently Associate Professor of the Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong. She is also the Medical Director (Non-Oncology) of the Phase 1 Clinical Trial Centre and serves as an honorary associate consultant at the Prince of Wales Hospital. Dr Luk completed her specialist training in endocrinology, reproduction and metabolism in 2007. Her research interests include epidemiology of diabetes and diabetes-related complications, study of the aetiology and mechanisms of young-onset diabetes, as well as translational studies of care models in people with diabetes.

Diabetes in Women: Maria Inês Schmidt

Maria Inês Schmidt MD, PhD is an endocrinologist and epidemiologist trained at John Hopkins Hospital and the University of North Carolina. She is Professor at the School of Medicine of the Federal University of Rio Grande do Sul, Brazil where she teaches medical students and graduate students in epidemiology. Her main research focuses on the epidemiology of type 2 diabetes, obesity, gestational diabetes, and diabetes prevention in women. Current main projects include: LINDA Brasil, a randomized controlled trial for the prevention of diabetes in women with recent gestational diabetes; ELSA-Brasil, a cohort study of 15105 Brazilian adults now followed-up for 10 years; Surveillance of diabetes and its complications in Brazil; and the Global Burden of Disease (GBD) project. Over the years, she has contributed to the development of IDF guidelines and acted as a panel member on various WHO consultations related to diabetes. She is a member of the Lancet Commission on Diabetes.

Education and Integrated Care: Zilin Sun

Zilin Sun M.D., Ph.D., is Professor of Medicine and Director of the Institute of Diabetes at Southeast University, Nanjing, China. Dr. Sun received his doctoral trainings in Clinical Pharmacology and Clinical Medicine from China Pharmaceutical University and Ulm University in Germany. He is currently Chair of the Chinese Association of Diabetes and Microcirculation and a Committee Member of the Chinese Society of Endocrinology. He was previously Vice Director of the Diabetes Education and Management Group of the Chinese Diabetes Society, a Committee member of Chinese Diabetes Society and Chair of the Jiangsu Diabetes Society. Dr. Sun is on the editorial board of “BMC Med” and “Diabetes Metab J” and has published more than 200 scientific papers, including more than 100 SCI-indexed publications.

Epidemiology and Public Health: Ayesha Motala

Ayesha Motala is a specialist physician and currently Professor and Clinical Head in the Department of Diabetes and Endocrinology at Inkosi Albert Luthuli Central Hospital affiliated to the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. Her research has focussed on the epidemiology, genetic and clinical aspects of diabetes and other non-communicable diseases (NCDs). She has been involved in several large-scale population studies, both cross-sectional and longitudinal, on the epidemiology of diabetes in African (black) and Asian Indian communities in KwaZulu Natal. She is the lead principal investigator of a large consortium-wide study at 10 sites across 7 countries in sub-Saharan Africa - the Human Hereditary and Health in Africa (H3Africa) study on diabetes, funded through the Wellcome Trust.

Living with Diabetes: Sana Ajmal

Sana Ajmal is a seasoned diabetes advocate, with years of experience with various IDF programmes and activities, including Young Leaders in Diabetes, the Diabetes Education Consultative Section and the IDF Congress. She is the Founder and Executive Director of Meethi Zindagi, the only national, people-centric, non-profit organization in Pakistan providing psychosocial support, peer education and medicines to the diabetes community. Her distinction lies in tailoring international best practices to a local perspective and simplifying complex solutions with an engineered approach and technology to create robust systems and services in resource-limited settings.

Clinical, Therapeutic and Technology Research: Shashank Joshi

Shashank R. Joshi is the Chair of the IDF Southeast Asian Region and Dean of the Indian College of Physicians from Mumbai, India. He is Past President of the Endocrine Society of India, RSSDI and many other societies in India and Asia. He is a well-known endocrinologist attached to Joshi Clinic and Lilavati Hospital and has published more than 800 publications and written 100 books. His areas of interest include diabetes and obesity therapy and developing low-cost interventions for the developing world.

Health Services and Policy: Niti Pall

Niti Pall is President of IDF Europe. She is Global Medical Director for KPMG and Senior Mobile Health Advisor for AXA. She also sits on the board of the Birmingham Women’s and Children’s Hospital. Niti is a senior Doctor who has deep expertise in primary care models and health benefit management across the world. Niti helped to build up the largest chain of primary care clinics in the UK – the Modality Partnership – and held several senior commissioning roles in the English NHS. She has innovated with new extended primary care and enhanced primary care including diabetes care across the world. Her interest in diabetes spans three decades, starting when her son was diagnosed with type 1 diabetes. She is passionate about involving patients in driving good quality services.

Learning objectives

Basic and Translational Science (BTS)

Clinical, Therapeutic and
Technology Research (CTT)

Diabetes Complications and
Comorbidities (DCC)

Diabetes in Women (DIW)

Education and Integrated Care (EIC)

Epidemiology and Public Health (EPH)

Health Services and Policy (HSP)

Living with Diabetes (LWD)

This stream addresses recent progress in diabetes research and its future applications in diabetes care as well as the latest advances in science-based clinical practice.

This stream deals with current and future areas of clinical therapeutics, diabetes technology and future research direction.

This stream deals with current and future areas of clinical therapeutics, diabetes technology and future research direction.

This stream will focus on the best evidence to treat and prevent diabetes and related conditions among women, including hyperglycaemia in pregnancy (HIP) and its long-term effects on mother and child.

This stream focuses on all aspects related to diabetes education and diabetes self-management and support, with a particular interest on diabetes care delivered by healthcare providers, peers, families, or communities, as well as on diabetes management systems/models integrated with tools dealing with diabetes detection, glucose monitoring, diet, or physical activity.

This stream deals with updates on recent research and advances on the epidemiology of diabetes diagnosis, complications and prevention, the public health challenges being faced and how to prevent and deal with them.

This stream will focus on health systems and policies that affect diabetes care, and most importantly people living with diabetes. There will be a focus on both the wider funding of healthcare in general,
and on policies that impact diabetes care at a micro and macro level.

The stream gives an in-depth insight into the perspectives of people living with diabetes and highlights their role in diabetes awareness, prevention, education, support, advocacy and communication.

Share
Share
Share